Industry
Rafa Laboratories
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
50.0%-37% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 80/100
Failure Rate
50.0%
2 terminated/withdrawn out of 4 trials
Success Rate
50.0%
-36.5% vs industry average
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Phase 1
1(25.0%)
Phase 2
1(25.0%)
Phase 3
1(25.0%)
Phase 4
1(25.0%)
4Total
Phase 1(1)
Phase 2(1)
Phase 3(1)
Phase 4(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (4)
Showing 4 of 4 trials
NCT04679623Phase 1Completed
Study of Midazolam in Healthy Adults
Role: lead
NCT00285051Phase 2Terminated
Comparison of Delta-8-THC to Ondansetron in the Prevention of Acute Nausea From Moderately Emetogenic Chemotherapy
Role: lead
NCT00557427Phase 4Terminated
Hypericum vs Fluoxetine for Mild to Moderate Adolescent Depression
Role: lead
NCT00128739Phase 3Completed
Treatment of Gastro-Intestinal and/or Hepatic Graft Versus Host Disease With Budesonide in Patients Following Peripheral Blood Stem Cell Transplantation
Role: lead
All 4 trials loaded